Susquehanna International Group
BLCM

Susquehanna International Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Susquehanna International Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,177
Closed -$9.96K – 13651
2023
Q1 		$9.96K Sell
30,177
-12,133
-29% -$11.2K ﹤0.01% 12210
2022
Q4 		$30.5K Buy
42,310
+12,616
+42% +$12.5K ﹤0.01% 11617
2022
Q3 		$36K Sell
29,694
-7,724
-21% -$9.84K ﹤0.01% 12390
2022
Q2 		$44K Buy
37,418
+20,697
+124% +$31.3K ﹤0.01% 12048
2022
Q1 		$36K Buy
+16,721
New +$27.2K ﹤0.01% 12449
2020
Q1 		– Sell
-7,461
Closed -$80.1K – 11106
2019
Q4 		$96K Buy
7,461
+6,407
+608% +$59.1K ﹤0.01% 9160
2019
Q3 		$11K Sell
1,054
-23,736
-96% -$310K ﹤0.01% 10014
2019
Q2 		$421K Buy
24,790
+16,904
+214% +$457K ﹤0.01% 7631
2019
Q1 		$266K Buy
7,886
+848
+12% +$28.3K ﹤0.01% 7414
2018
Q4 		$206K Buy
+7,038
New +$312K ﹤0.01% 7689
2018
Q3 		– Sell
-8,418
Closed -$570K – 10523
2018
Q2 		$621K Sell
8,418
-6,810
-45% -$531K ﹤0.01% 6377
2018
Q1 		$999K Sell
15,228
-13,845
-48% -$1.05M ﹤0.01% 5242
2017
Q4 		$2.44M Sell
29,073
-7,946
-21% -$779K ﹤0.01% 3564
2017
Q3 		$4.28M Buy
37,019
+9,952
+37% +$1.05M ﹤0.01% 2707
2017
Q2 		$3.16M Sell
27,067
-3,429
-11% -$426K ﹤0.01% 3069
2017
Q1 		$3.76M Buy
30,496
+22,936
+303% +$3M ﹤0.01% 2689
2016
Q4 		$1.03M Buy
7,560
+5,480
+263% +$973K ﹤0.01% 5477
2016
Q3 		$414K Buy
+2,080
New +$358K ﹤0.01% 6401
2016
Q2 		– Sell
-6,881
Closed -$766K – 9527
2016
Q1 		$643K Buy
6,881
+3,434
+100% +$374K ﹤0.01% 5941
2015
Q4 		$699K Buy
3,447
+787
+30% +$141K ﹤0.01% 6146
2015
Q3 		$386K Sell
2,660
-1,753
-40% -$322K ﹤0.01% 7611
2015
Q2 		$939K Buy
4,413
+1,311
+42% +$321K ﹤0.01% 6354
2015
Q1 		$719K Buy
+3,102
New +$750K ﹤0.01% 6404

Other funds holding BLCM

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Susquehanna International Group's BLCM Position: Q2 2023 in Review

Susquehanna International Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 30,177 shares — an estimated $9.96K sold.

Susquehanna International Group first reported a position in BLCM in Q1 2015 and held it in 23 quarters. The position peaked at $4.28M in Q3 2017. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

  • Susquehanna International Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 30,177 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $9.96K.
  • Susquehanna International Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 23 quarters.
  • Susquehanna International Group's Bellicum Pharmaceuticals, Inc. position peaked at $4.28M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.